2026年
(426) Suzuki, T., Kita, Y., Yanagida, K., Maeda, K., Hashidate-Yoshida, T., Nakanishi, H., Ohto-Nakanishi, T., Terada-Hirashima, J., Tsujimoto, Y., Hojo, M., Mitsuya, H., Shimizu, T., Shindou, H. Molecular signature of COVID-19 prior to its exacerbation by multi-omics survey.PLoS One 21 (2026) e0352423. DOI: 10.1371/journal.pone.0352423.
(425) Suzuki, T., Yanagida, K., Shimizu, T., Shindou, H. Responsible cell type in murine PAF-induced systemic anaphylaxis. Biochim Biophys Acta Mol Cell Biol Lipids. 2026 Apr 13;1871(4):159744. doi: 10.1016/j.bbalip.2026.159744.
(424) Yasuda, D., Sato, N., Yanagida, K., Hashidate-Yoshida, T., Shiiya, T., Shindou, H., Taira, A., Ebihara, T., Shimizu,T., Hirashima, M., Mizuno, S., Takahashi, S., Ishii, S. Lysophosphatidic acid–mediated NF-κB activation promotes FOXC2 expression essential for lymphatic valve development. J Clin Invest. 2026 Jan 13:e193364. doi: 10.1172/JCI193364.